• Contact
  • Jobs
  • Newsletter
  • Become a member
  • FR
  • EN
Hit enter to search or ESC to close
BiowinBiowin
  • Services
    • R&I
      • Cluster competitiveness calls
      • Additional funding tools
      • Investment support
    • International
      • Overview
      • International Missions
      • Europe
      • Walloon Investment Support
    • Finance
    • Communication
  • Projects
  • Members
    • Become a member
    • BioWin’s members
    • Partners
  • News & Events
    • News
    • Events
    • Blog
  • About Us
    • Mission & Vision
    • Ecosystem
    • Strategic Areas
    • Team
    • Governing Board
  • Resources
Syndesi Therapeutics
BiopharmacyFull MemberS

Syndesi Therapeutics

admin January 21, 2021 March 17th, 2021

Syndesi’s goal is to demonstrate the potential of novel modulators of SV2A to reduce the symptoms of cognitive impairment in patients with Alzheimer’s Disease and related conditions.

Website

Biopharmacy Full Member S No Comments
Share Tweet Share


Maison de l’Industrie Technologique
Rue Auguste Piccard, 20
6041 Gosselies (Belgium)
Tel : +32 71 91 92 85
Email : [email protected]

 

Cookies and privacy policy

 

I want to:

Build an innovative project
Expand my international network
Identify investment opportunities
View available jobs
Contact a member of the team

© 2021 Biowin.

  • Services
    • R&I
      • Cluster competitiveness calls
      • Additional funding tools
      • Investment support
    • International
      • Overview
      • International Missions
      • Europe
      • Walloon Investment Support
    • Finance
    • Communication
  • Projects
  • Members
    • Become a member
    • BioWin’s members
    • Partners
  • News & Events
    • News
    • Events
    • Blog
  • About Us
    • Mission & Vision
    • Ecosystem
    • Strategic Areas
    • Team
    • Governing Board
  • Resources
  • Contact
  • Jobs
  • Newsletter
  • Become a member
  • FR
  • EN